Capravirine

HCID 1783

Grundinformationen

CAS
178979-85-6
Standard-SMILES
CC(C)c1nc(COC(N)=O)n(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1
InChIKey
YQXCVAGCMNFUMQ-UHFFFAOYSA-N
Summenformel
C20H20Cl2N4O2S
Durchschnittliche Molmasse
451,4 g/mol
Monoisotopische Masse
450,06840224

Überblick

Capravirine is a non-nucleoside reverse transcriptase inhibitor. Capravirine shows antiviral activity against wild-type HIV as well as HIV strains with mutations in reverse transcriptase. Due to no statistically-significant difference between standard triple-drug HIV therapies and the same therapy with capravirine, its development was discontinued by the developer.

Namen und Bezeichner

Bevorzugter Name
Capravirine
IUPAC
[5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl]methyl carbamate
Englischer Name
Capravirine
Summenformel
C20H20Cl2N4O2S
Molmasse
451.37

Namen und Synonyme

Capravirine178979-85-6S-1153CapravirinaVHC779598XAG 549AG1549S 1153DTXSID301706891H-Imidazole-2-methanol, 5-((3,5-dichlorophenyl)thio)-4-(1-methylethyl)-1-(4-pyridinylmethyl)-, carbamate (ester)5-((3,5-Dichlorophenyl)thio)-4-isopropyl-1-(4-pyridylmethyl)imidazole-2-methanol carbamate (ester)capravirinum
Weitere Namen anzeigen
CdimiAGI 549Aids058025Aids-058025Capravirine D6YQXCVAGCMNFUMQ-UHFFFAOYSA-N5-(3,5-Dichlorophenyl)thio-4-isopropyl-1-(4-pyridyl)methyl-1H-imidazol-2-ylmethyl carbamate1H-Imidazole-2-methanol, 5-[(3,5-dichlorophenyl)thio]-4-(1-methylethyl)-1-(4-pyridinylmethyl)-, 2-carbamate
(5-((3,5-dichlorophenyl)sulfanyl)-4-(propan-2-yl)-1-(pyridin-4-ylmethyl)-1H-imidazol-2-yl)methyl carbamate{5-[(3,5-dichlorophenyl)sulfanyl]-4-(propan-2-yl)-1-(pyridin-4-ylmethyl)-1H-imidazol-2-yl}methyl carbamate5-[(3,5-Dichlorophenyl)thio]-4-isopropyl-1-(4-pyridylmethyl)imidazole-2-methanol carbamate (ester)RefChem:573747DTXCID0093180(5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl)methyl aminoformateS1153AG 1549

Datenbank-Bezeichner

CAS
178979-85-6
PubChem CID
1783
DTXSID
DTXSID30170689
ChEMBL
CHEMBL435128
UNII
VHC779598X
Nikkaji
J956.384I

Eigenschaften

Berechnete Struktureigenschaften

XLogP
4,5
Polarare Oberfläche (TPSA)
108 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
5
Frei drehbare Bindungen
8
Schwere Atome
29

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15

Physikochemische Eigenschaften

Schmelzpunkt
88 ° · 88° (dec)
Siedepunkt
646 · 646.0±55.0 °C(Predicted)
Dichte
1.4 · 1.40±0.1 g/cm3(Predicted)
pka
13.01 · 13.01±0.50(Predicted)

Chemie und Industrie

Pharmakologische Informationen

MeSH Pharmacological Classification · 2 Einträge

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Anwendungen

VerwendenAntiviral (reverse transcriptase inhibitor).

Anbieter8 Anbieter

LGM Pharma1-(800)-881-8210 · [email protected]
上海梅凯科技有限公司021-68689288 15300790979 · [email protected]
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]

Zugehörige Reaktionen

8

Notizen zur Verbindung

Wird geladen…